KRYSTAL BIOTECH INC (KRYS:NASDAQ)
$336.67 -0.01 (-0.003%)
Analysed KRYSTAL BIOTECH INC (KRYS:NASDAQ) News Sources
Krystal Biotech Shares Slide Despite Earnings Beat as Revenue Misses Forecasts
03-08-2026
advfn.com
Krystal Biotech Q2 Earnings Call Highlights
03-08-2026
marketbeat.com
Krystal Biotech Inc (KRYS) (Q2 2026) Earnings Call Highlights: VYJUVEK Sales Surge 24% as ...
03-08-2026
yahoo.com
J&J pharma leader to retire; Krystal slumps on gene therapy miss
04-08-2026
biopharmadive.com
Krystal Biotech (KRYS) Q2 2026 Earnings Call Transcript
11-08-2026
fool.com
Here Are Friday’s Top Wall Street Analyst Research Calls: Cinemark, Digital Realty, Fox Corporation, Krystal Biotech, LTC Properties, Roku, Sandisk, T-Mobile US, Wayfair, and More
14-08-2026
247wallst.com
Krystal Biotech Seen Positioned for Further Gains on Vyjuvek, Pipeline Readouts, RBC Says
14-08-2026
yahoo.com
Krystal Biotech (KRYS) Up 12% Since Last Earnings Report: Can It Continue?
02-09-2026
yahoo.com
Krystal Biotech to Present at 2026 Cantor Global Healthcare Conference
03-09-2026
yahoo.com
Krystal Stock Gains 13.4% in a Month: What Is Driving the Rally?
03-09-2026
yahoo.com
What is the current price of KRYSTAL BIOTECH INC (KRYS:NASDAQ)?
The current price of KRYSTAL BIOTECH INC (KRYS:NASDAQ) is $336.67.
KRYSTAL BIOTECH INC (KRYS:NASDAQ) absolute price change since previous trading day?
The absolute price change of KRYSTAL BIOTECH INC (KRYS:NASDAQ) since the previous trading day is $-0.01.
KRYSTAL BIOTECH INC (KRYS:NASDAQ) percentage price change since previous trading day?
The percentage price change of KRYSTAL BIOTECH INC (KRYS:NASDAQ) since the previous trading day is -0.003%.
What is the most recent average sentiment score for KRYSTAL BIOTECH INC (KRYS:NASDAQ)?
The most recent average sentiment score for KRYSTAL BIOTECH INC (KRYS:NASDAQ) is 68 out of 100.
What is the most recent average sentiment for KRYSTAL BIOTECH INC (KRYS:NASDAQ)?
The most recent sentiment for KRYSTAL BIOTECH INC (KRYS:NASDAQ) is .
SEC-8K** Filing Available For KRYSTAL BIOTECH INC (KRYS:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.